Indaptus Therapeutics Correlations

INDP Stock  USD 0.66  0.06  8.33%   
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Indaptus Therapeutics Correlation With Market

Good diversification

The correlation between Indaptus Therapeutics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.

Moving against Indaptus Stock

  0.44LUCD Lucid DiagnosticsPairCorr
  0.4PG Procter GamblePairCorr
  0.38WM Waste ManagementPairCorr
  0.44DD Dupont De NemoursPairCorr
  0.4T ATT Inc Sell-off TrendPairCorr
  0.38INTC Intel Sell-off TrendPairCorr
  0.35JNJ Johnson Johnson Sell-off TrendPairCorr
  0.34IBM International BusinessPairCorr
  0.32XOM Exxon Mobil Corp Earnings Call Next WeekPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
QNRXFBRX
KTTAFBRX
TPSTRZLT
FBRXRZLT
LGVNQNRX
KTTARZLT
  
High negative correlations   
ABVCTPST
ABVCRZLT
QNRXNTRB
LGVNNTRB
NTRBKTTA
NTRBFBRX

Risk-Adjusted Indicators

There is a big difference between Indaptus Stock performing well and Indaptus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Indaptus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RZLT  3.06 (0.49) 0.00 (0.59) 0.00 
 5.62 
 22.04 
TPST  2.33 (0.05) 0.00  0.06  0.00 
 4.55 
 17.36 
CMRA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
FBRX  5.65 (1.36) 0.00 (3.23) 0.00 
 9.14 
 28.46 
ABVC  4.05  0.70  0.12 (12.89) 4.51 
 9.80 
 32.39 
KTTA  5.20 (0.93) 0.00  1.30  0.00 
 8.14 
 53.63 
BTTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NTRB  6.15  1.34  0.23  2.12  5.10 
 17.09 
 54.72 
QNRX  5.38 (0.85) 0.00  1.79  0.00 
 14.29 
 57.78 
LGVN  3.39  0.15  0.05 (0.77) 3.69 
 6.37 
 16.74 

Indaptus Therapeutics Corporate Management

MD MBAChief OfficerProfile
Jeffrey MecklerCEO DirectorProfile
Walt EsqChief OfficerProfile
Michael NewmanChief FounderProfile
Boyan MDChief OfficerProfile